Imatron to use EBT in German cardiac study

Article

Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.Researchers plan to recruit 4500 men and women from a random

Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.

Researchers plan to recruit 4500 men and women from a random sample of the general population of the Ruhr industrial district in Germany. The study will focus on the direct detection of atherosclerosis instead of on risk factors that predict the probability of the disease.

EBT coronary calcium detection scanning will be compared with other measures of atherosclerosis in other vessels such as the carotid and peripheral arteries.

Imatron’s primary product is the EBT scanner, which is now in use at more than 120 imaging facilities around the world.

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.